RX PLUS STORY

Serial Number 88943726
606

Registration Progress

Application Filed
Jun 2, 2020
Under Examination
May 11, 2021
Approved for Publication
Mar 16, 2021
Published for Opposition
Mar 16, 2021
Registered

Basic Information

Serial Number
88943726
Filing Date
June 2, 2020
Published for Opposition
March 16, 2021
Abandonment Date
June 17, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 17, 2024
Classes
044

Rights Holder

Astellas Pharma Inc.

03
Address
5-1, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411
JP

Ownership History

Astellas Pharma Inc.

Original Applicant
03
Chuo-ku, Tokyo JP

Astellas Pharma Inc.

Owner at Publication
03
Chuo-ku, Tokyo JP

Legal Representation

Attorney
Christian S. Morgan

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

48 events
Date Code Type Description
Jul 12, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 17, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jan 18, 2024 DOCK D ASSIGNED TO EXAMINER
Nov 14, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 13, 2023 EX5G S SOU EXTENSION 5 GRANTED
Nov 8, 2023 EXT5 S SOU EXTENSION 5 FILED
Nov 8, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
May 2, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 28, 2023 EX4G S SOU EXTENSION 4 GRANTED
Apr 28, 2023 EXT4 S SOU EXTENSION 4 FILED
Apr 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 21, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 19, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 19, 2022 EX3G S SOU EXTENSION 3 GRANTED
Oct 19, 2022 EXT3 S SOU EXTENSION 3 FILED
Jun 3, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 3, 2022 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 3, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 3, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 18, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2022 EX2G S SOU EXTENSION 2 GRANTED
May 17, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 10, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 10, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2022 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 10, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 10, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 10, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 10, 2022 EXT2 S SOU EXTENSION 2 FILED
May 10, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 6, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 4, 2021 EX1G S SOU EXTENSION 1 GRANTED
Nov 4, 2021 EXT1 S SOU EXTENSION 1 FILED
Nov 4, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
May 11, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 16, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 16, 2021 PUBO A PUBLISHED FOR OPPOSITION
Feb 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 6, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 3, 2020 GNRT F NON-FINAL ACTION E-MAILED
Sep 3, 2020 CNRT R NON-FINAL ACTION WRITTEN
Aug 30, 2020 DOCK D ASSIGNED TO EXAMINER
Jun 24, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 5, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 044
Medical services; medical diagnostic testing services; surgery support services related to medical care for type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology-related conditions and disorders, arrhythmia and bile duct related conditions and disorders

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RX"